CD274 and malignant colon neoplasm: We observed similar immunogenic responses as we were developing a syngeneic mouse model bearing CT26 colon cancer cells to evaluate immune checkpoint inhibitor therapies using rat-derived anti-mouse PD-L1 antibodies.